About Daniel Fine
Form D filings for Cessation Therapeutics in 2024 list Daniel Fine as director.
Daniel Fine first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Daniel Fine in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Daniel Fine works with at each company, as listed on that company's latest Form D.
Cessation Therapeutics, Inc. · Form D, Apr 3, 2024